Stockholm, April 25, 2022 - Intervacc AB (publ) announces positive results from a proof-of-concept study where piglets from vaccinated sows were protected against experimental challenge with Streptococcus ... Read more
Stockholm, April 6, 2022 - Intervacc AB (publ) announces that the company's 2021 Annual Report has been published today. The annual report (in Swedish) is attached and an English unaudited translation of the report is ... Read more
Stockholm, March 23, 2022 - Intervacc announces today that the first batch of Strangvac®, a vaccine against equine Strangles, has been released for sale in Sweden.
“Strangvac® has now ... Read more
Stockholm, March 9, 2022 - The European Medicines Agency has today, after reviewing stability data, approved the extension of the shelf life of the antigens in Strangvac to 28 months.
The period in summary
January 1 – December 31, 2021
- The European Commission granted in August a Marketing ... Read more